DEA Schedule CII

Strength

5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1

NDC

31722018801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214959

On Market Since

9/29/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.4%

3M

-0.9%

6M

-2.2%

1Y

-11.1%

3Y

-2.3%

5Y

N/A

All

+10.3%